SCHEMBL2401388

SCHEMBL2401388

N#Cc1cc(S(=O)(=O)NC2CCC(C(=O)N3CCN(C4CCC4)CC3)CC2)ccc1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
HPGD P15428 1/20 0.44
HTT P42858 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
IRAK4 Q9NWZ3 4/20 0.43
AKR1C3 P42330 1/20 0.43
ALDH1A1 P00352 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
HRH3 Q9Y5N1 2/20 0.40
DRD2 P14416 1/20 0.40
ADRA1D P25100 1/20 0.40
ADRA1A P35348 1/20 0.40
ADRA1B P35368 1/20 0.40
POLB P06746 2/20 0.39
ATM Q13315 1/20 0.39
PSEN1 P49768 2/20 0.38
PSEN2 P49810 2/20 0.38
APH1B Q8WW43 2/20 0.38
NCSTN Q92542 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2401393 1.00 KMT2A (0.44) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2403517 0.98 KMT2A (0.44) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2403521 0.98 KMT2A (0.44) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2404100 0.86 CNR1 (0.47) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2404102 0.86 CNR1 (0.47) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2402253 0.85 KMT2A (0.44) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2402257 0.85 KMT2A (0.44) KMT2AMEN1HPGDHTTTDP1
SCHEMBL2402269 0.84 HRH3 (0.53) KMT2AMEN1HPGDHTTIRAK4
SCHEMBL2402262 0.84 HRH3 (0.53) KMT2AMEN1HPGDHTTIRAK4
SCHEMBL2405848 0.84 NPSR1 (0.47) KMT2AMEN1HPGDHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8017773-B2 Cyclohexyl sulfonamide derivatives HOFFMANN-LA ROCHE INC. (US) 2011-09-13 US disclosed
EP-1979322-B1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HAVING H3 RECEPTOR ACTIVITY HOFFMANN LA ROCHE (CH) 2010-09-01 EP disclosed
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES NETTEKOVEN MATTHIAS 2010-05-13 US disclosed
US-20070173511-A1 Cyclohexyl sulfonamide derivatives F. HOFFMANN-LA ROCHE AG (CH) 2007-07-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100120791-A1 CYCLOHEXYL SULFONAMIDE DERIVATIVES HRH3, HRH4, HRH1 KMT2A 338/4885MEN1 3462/4885HPGD 1565/4885
US-20070173511-A1 Cyclohexyl sulfonamide derivatives HRH3, HRH4, HRH1 KMT2A 338/4885MEN1 3462/4885HPGD 1565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.